Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation

British Journal of Haematology

Volumn 103, Issue 3, 1998, Pages 871-876

  Tosetto, Alberto ^a   Rodeghiero, Francesco ^a   Martinelli, Ida ^b   De Stefano, Valerio ^c   Missiaclia, Edoardo ^a   Chiusolo, Patrizia ^c   Mannucci, Pier Mannuccio ^b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

FV Leiden; Homocysteine; Prothrombin; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; FEMALE; GENE MUTATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM;

FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; MALE; POINT MUTATION; POLYMORPHISM, GENETIC; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM;

EID: 0031761182     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01028.x     Document Type: Article

References (33)

1. Arruda, V.A., von Zuben, P.M., Chiaparini, L.C., Annichino-Bizzacchi, J.M. & Costa, F. (1997) The mutation Ala766-Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thrombosis and Haemostasis, 77, 818-821.
2. Bertina, R.M., Koeleman, B.P.C., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. & Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64-67.
3. Cattaneo, M., Tsai, M.Y., Bucciarelli, P., Taioli, E., Zighetti, M.L., Bignell, M. & Mannucci, P.M. (1997) A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk of deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arteriosclerosis. Thrombosis and Vascular Biology, 17, 1662-1666.
4. Cumming, A.M., Keeney, S., Salden, A., Bhavnani, M., Shwe, K.H. & Hay, C.R. (1997) The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population. British Journal of Haematology, 98, 353-355.
5. de Heijer, M., Blom, H.J., Gerrits, W.B., Rosendaal, F.R., Haak, H.L., Wijermans, P.W. & Bos, G.M.J. (1995) Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet, 345, 882-885.
6. Ehrenforth, S., Ludwig, G., Klinke, S., Scharrer, I. & Nowak-Gottl, U. (1998) The prothrombin 20210 A allele is frequently coinherited in young carriers of the factor V Arg 506 to Gln mutation with venous thrombophilia. Blood, 91, 2209-2210.
7. Falcon, C.R., Cattaneo, M., Panzeri, D., Martinelli, I. & Mannucci, P.M. (1994) High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arteriosclerosis and Thrombosis, 14, 1080-1083.
8. Ferraresi, P., Legnani, C., Quaglio, S., Castoldi, E., Marchetti, G. & Bernardi, F. (1997) Study of a G/A variation in the 3′ untranslated region of prothrombin mRNA in Italian patients with venous thrombosis. Thrombosis and Haemostasis, Suppl. I, 379-379.
9. Frezzato, M., Tosetto, & A., Rodeghiero, F. (1996) Validated questionnaire for the identification of previous personal or familial venous thromboembolism. American Journal of Epidemiology, 143, 1257-1265.
10. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J.H., den Heijer, M. Kluijtmans, L.A.J., van den Heuvel. L.P. & Rozen, R. (1995) A candidate genetic risk factor of vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111-113.
11. Guttormsen, A.B., Ueland, P.M., Nesthus, I., Nygard, O., Schneede, J., Vollset, S.E. & Refsum, H. (1996) Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40μmol/liter). The Hordaland Homocysleine Study. Journal of Clinical Investigation, 98, 2174-2183.
12. Hillarp, A., Zoller, B., Svensson, P.J. & Dahlback, B. (1997) The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thrombosis and Haemostasis, 78, 990-992.
13. Jacques, P.F., Bostom, A.G., Williams, R.R., Ellison, R.C., Eckfeldt, J.H., Rosenberg, I.H., Selhub, J. & Rozen, R. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation, 93, 7-9.
14. Kahn, H.A. & Sempos, C.T. (1989) Statistical Methods in Epidemiology, Oxford University Press.
15. Kalafatis, M., Haley, P.E., Lu, D., Bertina, R.M., Long, G.L. & Mann, K.G. (1996) Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC) resistant individuals during clotting: an insight into the APC resistance assay. Blood, 87, 4695-4707.
16. Koeleman, B.P., Reitsma, P.H., Allaart, C.F. & Bertina, R.M. (1994) Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood, 84, 1031-1035.
17. Makris, M., Preston, F.E., Beauchamp, N.J., Cooper, P.C., Daly, M.E., Hampton, K.K., Bayliss, P. Peake, I.R. & Miller, G.J. (1997) Coinheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thrombosis and Haemostasis, 78, 1426-1429.
18. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. & Bertina, R. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with clevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698-3703.
19. Rees, D.C., Cox, M. & Clegg, J.B. (1995) World distribution of factor V Leiden. Lancet, 346, 1133-1134.
20. Ridker, P.M., Glynn, R.J., Miletich, J.P., Goldhaber, S.Z., Stampfer, M.J. & Hennekens, C.H. (1997a) Age-specific incidence rates of venous thromboembolisim among heterozygous carriers of factor V Leiden mutation. Annals of Internal Medicine, 126, 528-531.
21. Ridker, P.M., Hennekens, C.H., Selhub, J., Miletich, J.P., Malinow, M.R. & Stampfer, M.J. (1997a) Interrelation of hyperhomocyst(e)inemia. factor V Leiden, and risk of future venous thromboembolism. Circulation, 95, 1777-1782.
22. Rodeghiero, F. & Tosetto, A. (1993) Some remarks on the epidemiology of thrombotic disorders. Thrombosis and Haemostasis, 69, 527-528.
23. Rodeghiero, F. & Tosetto, A. (1996) The VITA Project. Population-based distribution of protein C, antithrombin II, heparin cofactor II and plasminogen: relationship with physiological variables and establishment of reference ranges. Thrombosis and Haemostasis, 76, 226-233.
24. Rodeghiero, F. & Tosetto, A. (1997) The epidemiology of inherited thrombophilia: the VITA Project. Thrombosis and Haemostasis, 78, 636-640.
25. StataCorp. (1997) Stata Statistical Software: Release 5.0. Stata Corporation. College Station. Texas.
26. Svensson, P.J. & Dahlback, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. New England Journal of Medicine, 330, 521-522.
27. Tosetto, A., Missiaglia, E., Frezzato, M. & Rodeghiero, F. (1997a) The VITA Project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism. British Journal of Haematology, 97, 804-806.
28. Tosetto, A., Missiaglia, E., Gatto, E. & Rodeghiero, E. (1997b) The Vita Project: phenotypic resistance to activated protein C and FV Leiden mutation in the general population. Thrombosis and Haemostasis, 78, 859-863.
29. Tosetto, A. & Rodeghiero, F. (1995) Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thrombosis and Haemostasis, 73, 732-73.
30. van Boven, H.H., Reitsma, P.H., Rosendaal, F.R., Bayston, T.A., Chowdhury, V., Bauer. K.A., Scharrer, I., Conard, J. & Lane, D. (1996) Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thrombosis and Haemostasis, 75, 417-421.
31. Vandenbroucke, J.P., Koster, T., Briet, E., Reitsma, P.H., Bertina, R. & Rosendaal, F.R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 344, 1453-1457.
32. Zoller, B., Berntsdotter, A., Garcia de Frutos, P. & Dahlback, B. (1995) Resistance to activated protein C as an additional risk factor in hereditary deficiency of protein S. Blood, 85, 3518-3523.
33. Zoller, B., Svensson, P.J., Dahlback, B. & Hillarp, A. (1998) The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families. Blood, 91, 2210-2211.